China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 948.30K | 983.50K | 1.23M | 756.20K | 1.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 948.30K | 983.50K | 1.23M | 756.20K | 1.03M |
| Cost of Revenue | 864.80K | 698.00K | 1.08M | 815.90K | 1.11M |
| Gross Profit | 83.60K | 285.50K | 150.80K | -59.70K | -87.00K |
| SG&A Expenses | 1.50M | 1.32M | 1.16M | 528.20K | 544.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.38M | 2.10M | 2.43M | 1.38M | 1.53M |
| Operating Income | -1.43M | -1.12M | -1.20M | -627.70K | -501.40K |
| Income Before Tax | -1.46M | -1.14M | -1.22M | -651.50K | -528.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.46M | -1.14M | -1.22M | -651.50K | -528.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.46M | -1.14M | -1.22M | -651.50K | -528.40K |
| EBIT | -1.43M | -1.12M | -1.20M | -627.70K | -501.40K |
| EBITDA | -330.00K | -136.70K | -702.30K | -271.70K | -180.60K |
| EPS Basic | -0.04 | -0.04 | -0.18 | -0.17 | -0.16 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.11 | -0.11 | -0.10 |
| EPS Diluted | -0.04 | -0.04 | -0.18 | -0.17 | -0.16 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.11 | -0.11 | -0.10 |
| Average Basic Shares Outstanding | 40.52M | 25.60M | 6.76M | 3.87M | 3.23M |
| Average Diluted Shares Outstanding | 40.52M | 25.60M | 6.76M | 3.87M | 3.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |